| Q41166424 | Clinical trials with thymosin |
| Q71065848 | Decreased antibody-dependent and spontaneous cell-mediated cytotoxicity in patients with chronic renal failure |
| Q71082628 | Lymphocytf Populations in Maintenance Hemodialysis Patients - Reassessment and Analysis of B Cell Subtypes |
| Q72960636 | Suppressor cells assayed by numerical and functional tests in chronic renal failure |
| Q43461453 | The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis |
| Q71483381 | The effect of uraemic "middle-sized molecules" on T lymphocyte functions |
| Q40720656 | The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of sixty-six melanoma patients |
| Q39831882 | Thymic peptide hormones: basic properties and clinical applications in cancer |
| Q66876137 | Thymus hormones |
| Q67742268 | Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vivo |
| Q39769727 | Use of Thymosin in the Treatment of Primary Immunodeficiency Diseases and Cancer |